Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07139769 · ClinicalTrials.gov registry record · NA
Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer
A NA study of Caregiving for Cancer, sponsored by Zeba Ahmad, Ph.D..
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT07139769: Recruiting NA study of Caregiving for Cancer, sponsored by Zeba Ahmad, Ph.D..
NCT07139769 is a NA study of Caregiving for Cancer that is actively recruiting participants, run by Zeba Ahmad, Ph.D.. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07139769, a NA study of Caregiving for Cancer, is actively recruiting participants, sponsored by Zeba Ahmad, Ph.D..
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Stress Management and Resiliency Training - Relaxation Response Resiliency Program; SMART-3RP(E. R. Park et al., 2021)), and iteratively incorporate feedback from parents of AYA with cancer using a mixed-methods approach. Next, the study team will pilot the refined intervention to assess for preliminary indicators of feasibility, acceptability, and potential for efficacy in reducing parental distress.
Primary Outcome
Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.
Conditions Studied
Interventions
- BEHAVIORAL Psychosocial Intervention for Parental Caregivers of AYA with Cancer
Study Locations (1)
Massachusetts
- Mass General Brigham Cancer Institute at Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2025-10-22 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT07139769 shows while recruiting
NCT07139769 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Caregiving for Cancer appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Intervention for Parental Caregivers of AYA with Cancer is the first listed.
NCT07139769 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07139769 about?
NCT07139769 is a clinical study titled "Adapting Psychosocial Resiliency Intervention for Parents of Adolescents and Young Adults With Cancer". The study team aims to adapt a psychosocial intervention to reduce psychological distress among the caregiving parents of adolescents and young adults (aged 15-39) who have cancer. First, the study team will adapt an evidence-supported, group-based program for improving psychological resiliency (Str...
What is the current status of trial NCT07139769?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2025-10-22. Estimated completion is 2026-08-31.
What conditions does trial NCT07139769 study?
This clinical trial studies the following conditions: Caregiving for Cancer.
What interventions are being tested in trial NCT07139769?
The interventions under investigation include: Psychosocial Intervention for Parental Caregivers of AYA with Cancer (BEHAVIORAL).
Who is sponsoring clinical trial NCT07139769?
This trial is sponsored by Zeba Ahmad, Ph.D., which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07139769 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07139769's enrollment target sits among peer trials
48 1382nd of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI